Literature DB >> 28833984

Psychosis in bipolar disorder: Does it represent a more "severe" illness?

Cynthia Z Burton1, Kelly A Ryan1, Masoud Kamali1,2, David F Marshall1, Gloria Harrington1, Melvin G McInnis1, Ivy F Tso1.   

Abstract

OBJECTIVES: Although there is a common clinical assumption that bipolar disorder with psychotic features reflects greater severity than bipolar disorder without psychosis, the existing empirical literature is mixed. This study investigated the phenomenology of psychosis as well as demographic, clinical, functional, and neuropsychological features in a large, cross-sectional sample of participants with bipolar disorder divided by history of psychosis.
METHODS: In a large single study, 168 affective-only bipolar disorder (BP-A) participants and 213 bipolar disorder with a history of psychosis (BP-P) participants completed a comprehensive clinical diagnostic interview and neuropsychological testing. t tests, chi-square tests, and Bayes factors were used to investigate group differences or lack thereof.
RESULTS: The prevalence of psychosis in this sample (53%) was similar to published reports. Nearly half of BP-P participants experienced grandiose delusions, and relatively few endorsed "first-rank" hallucinations of running commentary or two or more voices conversing. There were no demographic or neuropsychological differences between groups. BP-A participants experienced greater chronicity of affective symptoms and a greater degree of rapid cycling than BP-P participants; there were no other clinical differences between groups.
CONCLUSIONS: Overall, these results contradict the conventional notion that bipolar disorder with psychotic features represents a more severe illness than bipolar disorder without a history of psychosis. The presence of psychosis does not appear to be associated with poorer clinical/functional outcome or suggest a greater degree of neuropsychological impairment; conversely, the absence of psychosis was associated with affective chronicity and rapid cycling. Nosological and treatment implications are discussed.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  affective disorder; neuropsychological functioning; serious mental illness

Mesh:

Year:  2017        PMID: 28833984      PMCID: PMC5807194          DOI: 10.1111/bdi.12527

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  20 in total

1.  The Purdue pegboard; norms and studies of reliability and validity.

Authors:  J TIFFIN; E J ASHER
Journal:  J Appl Psychol       Date:  1948-06

2.  Co-occurrence of psychotic experiences and common mental health conditions across four racially and ethnically diverse population samples.

Authors:  J E DeVylder; D Burnette; L H Yang
Journal:  Psychol Med       Date:  2014-04-25       Impact factor: 7.723

3.  The Bidirectional Associations Between Psychotic Experiences and DSM-IV Mental Disorders.

Authors:  John J McGrath; Sukanta Saha; Ali Al-Hamzawi; Laura Andrade; Corina Benjet; Evelyn J Bromet; Mark Oakley Browne; Jose M Caldas de Almeida; Wai Tat Chiu; Koen Demyttenaere; John Fayyad; Silvia Florescu; Giovanni de Girolamo; Oye Gureje; Josep Maria Haro; Margreet Ten Have; Chiyi Hu; Viviane Kovess-Masfety; Carmen C W Lim; Fernando Navarro-Mateu; Nancy Sampson; José Posada-Villa; Kenneth S Kendler; Ronald C Kessler
Journal:  Am J Psychiatry       Date:  2016-03-17       Impact factor: 18.112

Review 4.  The neurocognitive profile of mood disorders - a review of the evidence and methodological issues.

Authors:  Richard J Porter; Lucy J Robinson; Gin S Malhi; Peter Gallagher
Journal:  Bipolar Disord       Date:  2015-12       Impact factor: 6.744

5.  The familial aggregation of psychotic symptoms in bipolar disorder pedigrees.

Authors:  J B Potash; V L Willour; Y F Chiu; S G Simpson; D F MacKinnon; G D Pearlson; J R DePaulo; M G McInnis
Journal:  Am J Psychiatry       Date:  2001-08       Impact factor: 18.112

6.  Suggestive linkage to chromosomal regions 13q31 and 22q12 in families with psychotic bipolar disorder.

Authors:  James B Potash; Peter P Zandi; Virginia L Willour; Tsuo-Hung Lan; Yuqing Huo; Dimitrios Avramopoulos; Yin Y Shugart; Dean F MacKinnon; Sylvia G Simpson; Francis J McMahon; J Raymond DePaulo; Melvin G McInnis
Journal:  Am J Psychiatry       Date:  2003-04       Impact factor: 18.112

7.  Experienced emotion and affect recognition in adult attention-deficit hyperactivity disorder.

Authors:  Lisa J Rapport; Sara R Friedman; Angela Tzelepis; Amy Van Voorhis; Sara L Friedman
Journal:  Neuropsychology       Date:  2002-01       Impact factor: 3.295

Review 8.  Prevalence and description of psychotic features in bipolar mania.

Authors:  E Dunayevich; P E Keck
Journal:  Curr Psychiatry Rep       Date:  2000-08       Impact factor: 5.285

9.  History of psychosis and previous episodes as potential explanatory factors for neurocognitive impairment in first-treatment bipolar I disorder.

Authors:  Christine Demmo; Trine Vik Lagerberg; Sofie R Aminoff; Tone Hellvin; Levi R Kvitland; Carmen Simonsen; Ole A Andreassen; Ingrid Melle; Torill Ueland
Journal:  Bipolar Disord       Date:  2016-03-18       Impact factor: 6.744

10.  The sensitivity and psychometric properties of a brief computer-based cognitive screening battery in a depression clinic.

Authors:  Scott A Langenecker; Angela F Caveney; Bruno Giordani; Elizabeth A Young; Kristy A Nielson; Lisa J Rapport; Linas A Bieliauskas; Matthew J Mordhorst; Sheila Marcus; Naomi Yodkovik; Kevin Kerber; Stanley Berent; Jon-Kar Zubieta
Journal:  Psychiatry Res       Date:  2007-04-19       Impact factor: 3.222

View more
  10 in total

1.  Longitudinal course and risk factors associated with psychosis in bipolar youths.

Authors:  Amit Shalev; John Merranko; Mary Kay Gill; Tina Goldstein; Fangzi Liao; Benjamin I Goldstein; Heather Hower; Neal Ryan; Michael Strober; Satish Iyengar; Martin Keller; Shirley Yen; Lauren M Weinstock; David Axelson; Boris Birmaher
Journal:  Bipolar Disord       Date:  2019-12-17       Impact factor: 6.744

2.  Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder.

Authors:  Milena Y Gotra; Scot K Hill; Elliot S Gershon; Carol A Tamminga; Elena I Ivleva; Godfrey D Pearlson; Matcheri S Keshavan; Brett A Clementz; Jennifer E McDowell; Peter F Buckley; John A Sweeney; Sarah K Keedy
Journal:  Schizophr Res       Date:  2020-07-14       Impact factor: 4.939

3.  Akt-mTOR hypoactivity in bipolar disorder gives rise to cognitive impairments associated with altered neuronal structure and function.

Authors:  Amanda M Vanderplow; Andrew L Eagle; Bailey A Kermath; Kathryn J Bjornson; Alfred J Robison; Michael E Cahill
Journal:  Neuron       Date:  2021-03-24       Impact factor: 17.173

4.  Explaining why childhood abuse is a risk factor for poorer clinical course in bipolar disorder: a path analysis of 923 people with bipolar I disorder.

Authors:  Steven Marwaha; Paul M Briley; Amy Perry; Phillip Rankin; Arianna DiFlorio; Nick Craddock; Ian Jones; Matthew Broome; Katherine Gordon-Smith; Lisa Jones
Journal:  Psychol Med       Date:  2019-09-18       Impact factor: 7.723

5.  Misdiagnosis, detection rate, and associated factors of severe psychiatric disorders in specialized psychiatry centers in Ethiopia.

Authors:  Getinet Ayano; Sileshi Demelash; Zegeye Yohannes; Kibrom Haile; Mikiyas Tulu; Dawit Assefa; Abel Tesfaye; Kelemua Haile; Melat Solomon; Asrat Chaka; Light Tsegay
Journal:  Ann Gen Psychiatry       Date:  2021-02-02       Impact factor: 3.455

6.  Integrative Genomic-Epigenomic Analysis of Clozapine-Treated Patients with Refractory Psychosis.

Authors:  Yerye Gibrán Mayén-Lobo; José Jaime Martínez-Magaña; Blanca Estela Pérez-Aldana; Alberto Ortega-Vázquez; Alma Delia Genis-Mendoza; David José Dávila-Ortiz de Montellano; Ernesto Soto-Reyes; Humberto Nicolini; Marisol López-López; Nancy Monroy-Jaramillo
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-04

7.  The efficacy of vitamin B6 as an adjunctive therapy to lithium in improving the symptoms of acute mania in patients with bipolar disorder, type 1; a double-blind, randomized, placebo-controlled, clinical trial.

Authors:  Rahim Badrfam; Seyed-Ali Mostafavi; Ali Khaleghi; Shahin Akhondzadeh; Atefeh Zandifar; Malihe Farid; Nami Mohammadian Khonsari; Mohammad Reza Mohammadi
Journal:  Brain Behav       Date:  2021-10-17       Impact factor: 2.708

8.  Composite immune marker scores associated with severe mental disorders and illness course.

Authors:  Monica Bettina Elkjaer Greenwood Ormerod; Thor Ueland; Maren Caroline Frogner Werner; Gabriela Hjell; Linn Rødevand; Linn Sofie Sæther; Synve Hoffart Lunding; Ingrid Torp Johansen; Torill Ueland; Trine Vik Lagerberg; Ingrid Melle; Srdjan Djurovic; Ole Andreas Andreassen; Nils Eiel Steen
Journal:  Brain Behav Immun Health       Date:  2022-07-02

9.  Psychotic symptoms in bipolar disorder and their impact on the illness: A systematic review.

Authors:  Subho Chakrabarti; Navdeep Singh
Journal:  World J Psychiatry       Date:  2022-09-19

10.  Sleep and Circadian Rhythm Disturbance in Remitted Schizophrenia and Bipolar Disorder: A Systematic Review and Meta-analysis.

Authors:  Nicholas Meyer; Sophie M Faulkner; Robert A McCutcheon; Toby Pillinger; Derk-Jan Dijk; James H MacCabe
Journal:  Schizophr Bull       Date:  2020-03-10       Impact factor: 9.306

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.